• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
april@madhedgefundtrader.com

Trade Alert - (BAC) November 13, 2024 - BUY

Trade Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-11-13 11:33:232024-11-13 11:33:23Trade Alert - (BAC) November 13, 2024 - BUY
april@madhedgefundtrader.com

Trade Alert - (C) November 13, 2024 - BUY

Trade Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-11-13 10:29:212024-11-13 10:29:21Trade Alert - (C) November 13, 2024 - BUY
april@madhedgefundtrader.com

November 13, 2024

Diary, Newsletter, Summary

Global Market Comments
November 13, 2024
Fiat Lux

 

Featured Trade:

(DON’T GET SCAMMED BY THE MUTUAL FUNDS),
(TESTIMONIAL)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-11-13 09:06:462024-11-13 10:50:31November 13, 2024
The Mad Hedge Fund Trader

Don't Get Scammed by the Mutual Funds

Diary, Newsletter, Research

How many mutual funds would you guess outperformed the stock market since the bull run started four years ago?

If you guessed 1,000, 100, or even 10, you would be dead wrong and even off by miles. In actual fact, not a single mutual fund has beaten the market since 2020.

Remember all those expensive, slickly produced TV ads boasting market-beating ratings and top quartiles?

You know, the ones that show an incredibly good-looking, but aging couple walking hand in hand into the sunset on a deserted beach?

They are all just so much bunk. The funds mentioned rarely quote performance beyond one or two short years.

Like my college math professor used to tell me, “Statistics are like a bikini bathing suit. What they reveal is fascinating, but what they conceal is essential.”

Recently, the New York Times studied the performance of 2,862 actively managed domestic stock mutual funds since 2010. It carried out a simple quantitative analysis, looking at how many managers stayed in the top performance quartile every year.

Their final conclusion zero.

It gets worse.

It is very rare for a manager to stay in the top quartile for more than one year. All too often, last year’s hero is this year’s goat.

The harsh lesson here is that investing with your foot on the gas pedal and your eyes on the rearview mirror is certain to get you into a fatal crash.

The Times did uncover two funds that stayed at the top for an impressive five years. They turned out to be small-cap energy funds that took inordinate amounts of risk to achieve these numbers and have since lost most of their money.

The reasons for the woeful underperformance are legion. Management fees are sky-high and grasping. Hidden costs are everywhere. Read the fine print in the prospectus, as I do, and you would be shocked, shocked.

Real talent is in short supply in the mutual fund industry, with all the real brains decamping to start their own 2%/20% hedge funds. The inside joke among hedge fund managers is that employment at a mutual fund is proof positive that you are a lousy manager.

Let’s go back to those glitzy TV ads, which cost millions to produce. If you are a mutual fund investor, you are paying for all of those too. They are made at the expense of a lower return on investment on your money.

And those sexy performance numbers? They benefit from a huge survivor bias. As soon as fund performance starts to tank, the managers close it, lest it pollute the numbers of other funds in the same family.

The number of funds with good, honest 20-year records can almost be counted on one hand.

Now, let me depress you even more.

An industry performance this poor underperforms random chance. That means chimpanzees throwing darts at the stock pages of the Wall Street Journal would generate a higher investment return than the entire mutual fund industry combined.

So much for all of those Harvard MBAs!

Are you ready to throw your empty beer can at the TV set yet?

If you think all of this stuff should be illegal, you are probably right. But since you watch TV, then you have probably been trained like a barking seal to oppose the regulation that would reign these people in.

This is what the attempt to kill the Dodd-Frank financial regulation bill is all about. The mutual fund industry complains bitterly that they are over-regulated and spend millions on lobbyists to get themselves off the hook. By the way, these expenses also come out of your fund performance as well.

These are all reasons why the Mad Hedge Fund Trader is able to generate such high-performance numbers year in and year out.

I am not charging you with any of my overhead. I am not jacking up your commissions. Nor am I selling your order flow to high-frequency traders for a tidy sum so they can front-run you.

Being a small operation of a dozen or so people, I’ll tell you what I don’t have. I lack an investment banking department telling me I have to recommend a stock so we can get the management of their next stock issue or a sweet M&A deal.

I am absent from a trading desk telling me I have to move this block of stock before the prices drop and my bonus gets cut.

And I am completely missing a boss screaming at me that if I don’t get my orders up, my wife would have to become a prostitute to support our family (yes, some asshole sales manager actually told me that once. I later heard he died of a heart attack).

You just need to pay me a low, flat annual fee, and I’m done. I don’t need any more. It’s up to you to search out the best deal you can get on executions.

Don’t even think about trying to give me your money to manage. I don’t want it.

This is why the overwhelming bulk of investors are better off investing in the cheapest Vanguard index fund they can find, diversifying holdings among a small number of major asset classes, and then rebalancing once a year (click here for my “Buy and Forget Portfolio”).

Welcome to the brave new world.

ChimpBut We're In the Top Quartile!

https://www.madhedgefundtrader.com/wp-content/uploads/2015/04/Chimp-e1428960498232.jpg 303 400 The Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png The Mad Hedge Fund Trader2024-11-13 09:04:332024-11-13 10:45:20Don't Get Scammed by the Mutual Funds
Mad Hedge Fund Trader

Testimonial

Diary, Newsletter, Testimonials

After losing money with a million different advisory services and registered brokers I finally found YOU, and YOU make it all worth it!!! Thanks a bunch. I have so much confidence in you!

Stefano
Quarona, Sesia, Italy

 

 

https://www.madhedgefundtrader.com/wp-content/uploads/2018/11/John-Thomas-bear.png 402 291 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2024-11-13 09:02:302024-11-13 10:45:07Testimonial
The Mad Hedge Fund Trader

November 13, 2024 - Quote of the Day

Diary, Newsletter, Quote of the Day

"In investment management, the progression is from the innovators to the imitators, to the swarming incompetents," said Oracle of Omaha, Warren Buffett.

https://www.madhedgefundtrader.com/wp-content/uploads/2017/03/Jim-Carrey-e1490318751893.jpg 198 300 The Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png The Mad Hedge Fund Trader2024-11-13 09:00:252024-11-13 10:44:40November 13, 2024 - Quote of the Day
april@madhedgefundtrader.com

Trade Alert - (TSLA) November 12, 2024 - BUY

Trade Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-11-12 14:31:192024-11-12 14:31:19Trade Alert - (TSLA) November 12, 2024 - BUY
april@madhedgefundtrader.com

Trade Alert - (TSLA) November 12, 2024 - TAKE PROFITS - SELL

Trade Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-11-12 13:54:172024-11-12 14:01:44Trade Alert - (TSLA) November 12, 2024 - TAKE PROFITS - SELL
april@madhedgefundtrader.com

November 12, 2024

Biotech Letter

Mad Hedge Biotech and Healthcare Letter
November 12, 2024
Fiat Lux

 

Featured Trade:

(MEDTECH’S TRUMP CARD)

(RMD), (STE), (TNDM), (JNJ), (BDX), (MDT), (BSX), (SYK), (ZBH)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-11-12 12:02:022024-11-12 13:00:23November 12, 2024
april@madhedgefundtrader.com

Medtech's Trump Card

Biotech Letter

After seeing Trump sweep back into office, my phone's been ringing off the hook with one question: "What happens to my portfolio now?"

Look, I've been around this circus since covering Reagan in the White House press corps, and I can tell you that market hysteria rarely matches reality.

But this time, we need to pay attention - especially in the $567 billion medtech industry that's about to face some serious disruption.

What's different now? Trump's not just talking about those 10% to 20% blanket tariffs anymore - he's dead serious about slapping a potential 60% tariff on Chinese imports.

And after spending years watching supply chains twist themselves into pretzels during COVID, this is going to hit different.

To understand just how big this could be, let's look at what's really at stake here.

In vitro diagnostics makes up 18% of the medtech industry, and cardiology devices are sitting at $75 billion in 2024, expected to hit $95 billion by 2028.

Those aren't just numbers on a page - they represent real money that could take a serious hit. If these tariffs go through, we're looking at a 3.2% hit to S&P 500 earnings per share in 2025.

And it gets worse - add another 1.5% drop if our trading partners decide to play hardball with retaliatory tariffs.

Given all this, where should you put your money? The answer lies in looking at who's already ahead of the curve.

Well, established players like Johnson & Johnson (JNJ) and Becton Dickinson and Co. (BDX) are looking increasingly shrewd with their local-for-local manufacturing strategy.

They might not give you the same adrenaline rush as scaling Mount Everest, but they're solid holds in this environment.

But they’re not the only companies securing their positions. ResMed (RMD), for instance, just posted third-quarter sales up 11% to $1.22 billion, with adjusted earnings jumping 34% to $2.20 per share.

That's not just good numbers - that's a company that knows how to execute regardless of who's in the White House.

In the same vein, Steris deserves attention. Their "front-shoring" strategy in Malaysia isn't just smart - it's prescient. After years of covering Asia for The Economist, I can spot smart positioning when I see it.

Now, let's talk about some of the bigger players in the room. Medtronic (MDT), our industry giant, is giving me pause.

Sure, they're a global leader, but their heavy reliance on Chinese manufacturing and components is about to become a serious headache under these new tariffs.

Same story with Boston Scientific (BSX) - they've got manufacturing facilities in China that could turn from assets to liabilities pretty quickly.

Stryker (SYK) and Zimmer Biomet (ZBH) are in the same boat, but with a twist. Both companies have been smart enough to spread their supply chains globally, but they're still catching enough Chinese exposure to make me nervous.

When those tariffs hit their component costs, watch their margins. This isn't just about bottom lines - it's about how much wiggle room these companies have to absorb higher costs without passing them on to hospitals and patients.

On the flip side, I'm watching companies like Tandem Diabetes Care (TNDM) with growing concern.

Their heavy Asian supply chain exposure under Trump's trade policies is going to be about as comfortable as my MIG-25 flight at 90,000 feet - and trust me, that wasn't comfortable at all.

But, what’s really telling is where the smart money is flowing.

Keep your eyes on three key trends that are reshaping the industry: supply chain resilience, M&A activity (now up 18% to $57.7 billion), and digital transformation.

About 30% of medtech companies are getting serious about digitizing their operations - and they're the ones to watch.

So, here's my bottom line: Trump's return is going to shake up medtech, but not every tremor is an earthquake.

The winners in this new landscape will be companies that have already diversified their manufacturing outside China, built up strong balance sheets to absorb these tariff impacts, and proven they can adapt - like ResMed and Steris have shown us.

The real champions will be those making serious investments in digital transformation. These are the companies that won't just survive Trump's trade policies - they'll thrive under them.

And if you're still holding onto companies with heavy Chinese exposure?

Well, let's just say it might be time to look for higher ground - and I'm speaking as someone who's made that call at both 20,000 feet on Everest and during the 2008 crash.

The medtech industry isn't going anywhere - people will always need medical devices. But which companies thrive under Trump's second term? That's going to depend on who's prepared for the storm and who's still standing in the open.

Now, if you'll excuse me, I've got some vintage wine to open. Making sense of these markets is thirsty work.

 

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-11-12 12:00:042024-11-12 13:00:07Medtech's Trump Card
Page 9 of 15«‹7891011›»

tastytrade, Inc. (“tastytrade”) has entered into a Marketing Agreement with Mad Hedge Fund Trader (“Marketing Agent”) whereby tastytrade pays compensation to Marketing Agent to recommend tastytrade’s brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastytrade and/or any of its affiliated companies. Neither tastytrade nor any of its affiliated companies is responsible for the privacy practices of Marketing Agent or this website. tastytrade does not warrant the accuracy or content of the products or services offered by Marketing Agent or this website. Marketing Agent is independent and is not an affiliate of tastytrade. 

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2025. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
  • Privacy Policy
  • Disclaimer
  • FAQ
Scroll to top